Research ArticleCancer

Myeloid cell–derived HOCl is a paracrine effector that trans-inhibits IKK/NF-κB in melanoma cells and limits early tumor progression

See allHide authors and affiliations

Science Signaling  06 Apr 2021:
Vol. 14, Issue 677, eaax5971
DOI: 10.1126/scisignal.aax5971

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling